4.0000
0.0000
(0.00%)
At close: January 30 at 9:15:03 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-712,004.0000
-726,077.0000
-653,915.0000
-604,679.0000
-609,956.0000
Investing Cash Flow
-44,582.0000
21,922.0000
-384,612.0000
-466,522.0000
-107,367.0000
Financing Cash Flow
310,023.0000
368,751.0000
619,268.0000
1,781,387.0000
1,040,003.0000
End Cash Position
943,428.0000
1,038,048.0000
1,345,639.0000
1,706,886.0000
1,019,979.0000
Capital Expenditure
-38,588.0000
-56,844.0000
-236,963.0000
-436,629.0000
-251,476.0000
Issuance of Capital Stock
533,945.0000
470,089.0000
19.0000
1,300,645.0000
634,217.0000
Issuance of Debt
209,417.0000
953,500.0000
763,617.0000
599,737.0000
527,805.0000
Repayment of Debt
-339,884.0000
-956,091.0000
-54,504.0000
-51,150.0000
-95,000.0000
Repurchase of Capital Stock
-7,882.0000
-5,923.0000
-26,776.0000
-25,874.0000
--
Free Cash Flow
-750,592.0000
-782,921.0000
-890,878.0000
-1,041,308.0000
-861,432.0000
12/31/2020 - 12/20/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PYPD PolyPid Ltd.
2.9899
+0.33%
TYRA Tyra Biosciences, Inc.
14.71
+0.41%
ANTX AN2 Therapeutics, Inc.
1.1700
-0.85%
AURA Aura Biosciences, Inc.
7.93
+0.13%
UPB Upstream Bio, Inc.
11.00
+7.32%
ALMS Alumis Inc.
6.72
+2.91%
MBX MBX Biosciences, Inc.
11.64
+13.34%
SLN Silence Therapeutics plc
5.25
+0.19%
LXEO Lexeo Therapeutics, Inc.
5.25
+0.77%
APGE Apogee Therapeutics, Inc.
42.50
+5.41%